Dell’Oro Group Releases New Optical Transport Forecast Report

In a newly released Optical Transport forecast report by Dell’Oro Group, the trusted source for market information about the networking and telecommunications industries, total optical packet product revenues are forecast to grow at a compounded annual growth rate (CAGR) of 19 percent over the next five years, approaching $11 billion by 2017.

“We believe optical transport equipment deployments will be driven by two main factors,” said Jimmy Yu, Vice President of Optical Transport Market Research at Dell’Oro Group. “The first will be the need to increase network capacity as economically as possible, which will drive the need for 100 Gbps DWDM wavelengths. We forecast 100 Gbps DWDM wavelength shipments to grow at an 80 percent CAGR. The second factor will be the need to transport packets more efficiently as data and video traffic dominate the network, driving the move towards Optical Packet Platforms,” added Mr. Yu.

Optical Packet Platform systems consist of three technology segments—Optical Packet-Transport, Optical Packet-Switch, and Optical Packet-Core Switch. Optical Packet-Transport systems are used for high capacity bandwidth management and transport, while Optical Packet-Switches are used for deterministic Ethernet services, and Optical Packet-Core Switches are used for network meshing and protection.

About the Report

The Dell’Oro Group Optical Transport 5-Year Forecast Report offers a complete overview of the Optical Transport industry with tables covering manufacturers’ revenue, average selling prices, unit shipments, Tributary/Line or Wavelength shipments (by speed up to 100 Gbps). The report tracks DWDM long haul terrestrial, WDM metro, multiservice multiplexers, and optical switch equipment. To purchase this report, call Julie Learmond-Criqui at +1.650.622.9400 x244 or email

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.